Novavax COVID Vaccine Results Are Promising, Hope Company Starts Trial On Children Soon: Centre

Novavax COVID Vaccine Results Are Promising, Hope Company Starts Trial On Children Soon: Centre

US-based Novavax, on Monday (June 14), announced that its recombinant nanoparticle protein-based COVID-19 vaccine demonstrated 100 per cent protection against moderate and severe disease from SARS-CoV-2 and 90.4 per cent overall efficacy in its "PREVENT-19 Phase III trials"
Coronavirus Outbreak, News
- in Coronavirus Outbreak, News
0
Novavax COVID Vaccine Results Are Promising, Hope Company Starts Trial On Children Soon: CentreCOVID-19 vaccine Novavax’s results are promising, said Dr VK Paul, Member-Health, Niti Aayog
Highlights
  • COVID vaccine Novavax will be produced in India: Dr VK Paul, Niti Aayog
  • Serum Institute of India will produce 1.1 billion doses of Novavax in India
  • Clinical trials in India in an advanced stage of completion: Dr VK Paul

New Delhi: The Centre on Tuesday (June 15) said clinical trials of the Novavax COVID-19 vaccine in India are in an advanced stage of completion and hoped the US-based company will soon start trials of its protein-based vaccine on children too. “Novavax results are promising. What we are learning from data available in the public domain that this vaccine is very safe and highly effective. It will be produced in India. Clinical trials are being conducted and are in an advanced stage of completion,” Dr VK Paul, Member-Health, Niti Aayog said in press briefing by the Union Health Ministry.

Also Read: Novavax COVID Vaccine Candidate Shows Overall 90 Per Cent Efficacy: Study

He said that Novavax vaccine will be produced in India, hopefully in very large quantities. Preparatory work has already been done by the Pune-based manufacturer Serum Institute of India, which has an agreement with the Maryland-based company to produce 1.1 billion doses of the vaccine in India. Dr Paul said there will be some gap in the production of the (of Novavax vaccine) for a while adding,

I am also hoping they (Novavax) would also start trials on children too.

Also Read: Centre Confirms First Death Following COVID Vaccination, Says ‘Benefits Of Vaccination Are Overwhelmingly Greater’

US-based Novavax, on Monday (June 14), announced that its recombinant nanoparticle protein-based COVID-19 vaccine demonstrated 100 per cent protection against moderate and severe disease from SARS-CoV-2 and 90.4 per cent overall efficacy in its “PREVENT-19 Phase III trials”.

The study involved 29,960 participants across 119 sites across the US and Mexico. In May this year the company had said that it has initiated a pediatric expansion of its Phase 3 clinical trial for its COVID vaccine candidate. The additional arm of the ongoing PREVENT-19 pivotal trial will evaluate the efficacy, safety and immunogenicity of NVX-CoV2373 in up to 3,000 adolescents aged 12-17 across up to 75 sites in the US. Meanwhile, Dr Paul pointed out that the COVID virus transmission is very low right now but people still need to be cautious.

Also Read: If You Extend Intervals Between The Vaccine Doses, You May Become Vulnerable To Variants: Dr Anthony Fauci To NDTV

Virus transmission is very low right now. We are dealing with a highly transmissible variant this year. Hence, we need to maintain greater caution and strictly abide by COVID19 appropriate behaviour, he added.

Meanwhile, India reported 60,471 new COVID-19 cases, the lowest count after 75 days, while the daily positivity rate further dropped to 3.45 per cent, according to the Ministry of Health and Family Welfare on Tuesday. The daily positivity rate is below 5 per cent for 8 consecutive days. The active cases further declined to 9,13,378, taking the weekly positivity rate at 4.39 per cent, while the national COVID-19 recovery rate has improved to 95.64 per cent. With the fresh cases, the country’s tally of cases has climbed to 2,95,70,881, as per Union Health Ministry.

Also Read: Two Doses Of COVID Vaccine ‘Highly Effective’ In Reducing Hospitalisation From The Delta Variant: UK Analysis

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

World

19,89,21,889Cases
6,44,02,340Active
13,02,83,678Recovered
42,35,871Deaths
Coronavirus has spread to 194 countries. The total confirmed cases worldwide are 19,89,21,889 and 42,35,871 have died; 6,44,02,340 are active cases and 13,02,83,678 have recovered as on August 3, 2021 at 3:55 am.

India

3,17,26,507 30,549Cases
4,04,9588,760Active
3,08,96,354 38,887Recovered
4,25,195 422Deaths
In India, there are 3,17,26,507 confirmed cases including 4,25,195 deaths. The number of active cases is 4,04,958 and 3,08,96,354 have recovered as on August 3, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths
Maharashtra

63,15,063 4,869

78,700 3,650

61,03,325 8,429

1,33,038 90

Kerala

34,25,473 13,984

1,65,834 2,057

32,42,684 15,923

16,955 118

Karnataka

29,08,284 1,285

24,045 123

28,47,627 1,383

36,612 25

Tamil Nadu

25,63,544 1,957

20,385 139

25,09,029 2,068

34,130 28

Andhra Pradesh

19,70,008 1,546

20,582 437

19,36,016 1,968

13,410 15

Uttar Pradesh

17,08,500 24

646 18

16,85,091 42

22,763

West Bengal

15,29,295 575

10,803 171

15,00,331 734

18,161 12

Delhi

14,36,401 51

538 44

14,10,809 95

25,054

Chhattisgarh

10,02,458 236

1,918 1

9,87,012 234

13,528 3

Odisha

9,79,737 1,032

13,318 820

9,60,386 1,785

6,033 67

Rajasthan

9,53,704 16

241 9

9,44,509 25

8,954

Gujarat

8,24,922 22

251 3

8,14,595 25

10,076

Madhya Pradesh

7,91,862 17

132 7

7,81,217 10

10,513

Haryana

7,69,956 14

703 12

7,59,614 25

9,639 1

Bihar

7,24,917 37

401 34

7,14,872 71

9,644

Telangana

6,45,997 591

8,819 54

6,33,371 643

3,807 2

Punjab

5,99,162 32

473 31

5,82,395 63

16,294

Assam

5,68,257 1,275

12,429 213

5,50,534 1,469

5,294 19

Jharkhand

3,47,223 23

239 15

3,41,855 38

5,129

Uttarakhand

3,42,198 37

574 35

3,34,261 71

7,363 1

Jammu And Kashmir

3,21,725 118

1,254 43

3,16,090 73

4,381 2

Himachal Pradesh

2,06,369 208

1,304 75

2,01,543 132

3,522 1

Goa

1,71,295 90

1,027 16

1,67,118 72

3,150 2

Puducherry

1,21,059 54

944 38

1,18,320 92

1,795

Manipur

99,872 541

9,814 591

88,480 1,120

1,578 12

Tripura

79,026 304

3,104 12

75,167 292

755

Meghalaya

65,939 350

5,843 200

58,987 537

1,109 13

Chandigarh

61,960 6

33 3

61,116 3

811

Arunachal Pradesh

48,565 305

3,508 167

44,823 469

234 3

Mizoram

40,111 748

12,316 127

27,642 618

153 3

Nagaland

28,004 59

1,300 44

26,130 99

574 4

Sikkim

26,880 126

3,323 131

23,211 256

346 1

Ladakh

20,345 5

57 0

20,081 5

207

Dadra And Nagar Haveli

10,650

15 9

10,631 9

4

Lakshadweep

10,207 12

79 4

10,078 8

50

Andaman And Nicobar Islands

7,539

6 1

7,404 1

129

Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like

Increased Risk Of Heart Attack, Stroke In First Two Weeks Following COVID-19: Lancet Study

The study published in the Lancet journal compared the occurrence of acute myocardial infarction or heart attack, and stroke in 86,742 COVID-19 patients with 3.48lakh control individuals in Sweden from February 1 to September 14, 2020